<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">27871313</PMID>
        <DateCompleted>
            <Year>2017</Year>
            <Month>09</Month>
            <Day>26</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1471-2407</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>16</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2016</Year>
                        <Month>11</Month>
                        <Day>22</Day>
                    </PubDate>
                </JournalIssue>
                <Title>BMC cancer</Title>
                <ISOAbbreviation>BMC Cancer</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Conservation of immune gene signatures in solid tumors and prognostic implications.</ArticleTitle>
            <Pagination>
                <MedlinePgn>911</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText Label="BACKGROUND">Tumor-infiltrating leukocytes can either limit cancer growth or facilitate its spread. Diagnostic strategies that comprehensively assess the functional complexity of tumor immune infiltrates could have wide-reaching clinical value. In previous work we identified distinct immune gene signatures in breast tumors that reflect the relative abundance of infiltrating immune cells and exhibited significant associations with patient outcomes. Here we hypothesized that immune gene signatures agnostic to tumor type can be identified by de novo discovery of gene clusters enriched for immunological functions and possessing internal correlation structure conserved across solid tumors from different anatomic sites.</AbstractText>
                <AbstractText Label="METHODS">We assembled microarray expression datasets encompassing 5,295 tumors of the breast, colon, lung, ovarian and prostate. Unsupervised clustering methods were used to determine number and composition of gene clusters within each dataset. Immune-enriched gene clusters (signatures) identified by gene ontology enrichment were analyzed for internal correlation structure and conservation across tumors then compared against expression profiles of: 1) flow-sorted leukocytes from peripheral blood and 2) &gt;300 cancer cell lines from solid and hematologic cancers. Cox regression analysis was used to identify signatures with significant associations with clinical outcome.</AbstractText>
                <AbstractText Label="RESULTS">We identified nine distinct immune-enriched gene signatures conserved across all five tumor types. The signatures differentiated specific leukocyte lineages with moderate discernment overall, and naturally organized into six discrete groups indicative of admixed lineages. Moreover, seven of the signatures exhibit minimal and uncorrelated expression in cancer cell lines, suggesting that these signatures derive predominantly from infiltrating immune cells. All nine immune signatures achieved statistically significant associations with patient prognosis (p&lt;0.05) in one or more tumor types with greatest significance observed in breast and skin cancers. Several signatures indicative of myeloid lineages exhibited poor outcome associations that were most apparent in brain and colon cancers.</AbstractText>
                <AbstractText Label="CONCLUSIONS">These findings suggest that tumor infiltrating immune cells can be differentiated by immune-specific gene expression patterns that quantify the relative abundance of multiple immune infiltrates across a range of solid tumor types. That these markers of immune involvement are significantly associated with patient prognosis in diverse cancers suggests their clinical utility as pan-cancer markers of tumor behavior and immune responsiveness.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Chifman</LastName>
                    <ForeName>Julia</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cancer Biology, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, 27157, NC, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pullikuth</LastName>
                    <ForeName>Ashok</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cancer Biology, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, 27157, NC, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chou</LastName>
                    <ForeName>Jeff W</ForeName>
                    <Initials>JW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cancer Biology, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, 27157, NC, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Biostatistical Sciences, Wake Forest Public Health Sciences, Medical Center Boulevard, Winston-Salem, 27157, NC, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bedognetti</LastName>
                    <ForeName>Davide</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sidra Medical and Research Center, Doha, Qatar.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Miller</LastName>
                    <ForeName>Lance D</ForeName>
                    <Initials>LD</Initials>
                    <Identifier Source="ORCID">0000-0003-3799-2528</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Cancer Biology, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, 27157, NC, USA. ldmiller@wakehealth.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>P30 CA012197</GrantID>
                    <Acronym>CA</Acronym>
                    <Agency>NCI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>T32 CA079448</GrantID>
                    <Acronym>CA</Acronym>
                    <Agency>NCI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
                <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2016</Year>
                <Month>11</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>BMC Cancer</MedlineTA>
            <NlmUniqueID>100967800</NlmUniqueID>
            <ISSNLinking>1471-2407</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D066264" MajorTopicYN="N">Datasets as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019143" MajorTopicYN="Y">Evolution, Molecular</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015972" MajorTopicYN="Y">Gene Expression Regulation, Neoplastic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007109" MajorTopicYN="N">Immunity</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007962" MajorTopicYN="N">Leukocytes</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058977" MajorTopicYN="N">Molecular Sequence Annotation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D059467" MajorTopicYN="Y">Transcriptome</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Consensus clustering</Keyword>
            <Keyword MajorTopicYN="Y">Enrichment scores</Keyword>
            <Keyword MajorTopicYN="Y">Immune signatures</Keyword>
            <Keyword MajorTopicYN="Y">Survival analysis</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2016</Year>
                <Month>03</Month>
                <Day>09</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2016</Year>
                <Month>11</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2016</Year>
                <Month>11</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2016</Year>
                <Month>11</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2017</Year>
                <Month>9</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">27871313</ArticleId>
            <ArticleId IdType="doi">10.1186/s12885-016-2948-z</ArticleId>
            <ArticleId IdType="pii">10.1186/s12885-016-2948-z</ArticleId>
            <ArticleId IdType="pmc">PMC5118876</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2014 Sep 02;9(9):e106397</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25181531</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 1992 Jul 15;52(14):4009-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1377602</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Immun. 2009 Apr 02;9:3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19338264</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2011;6(12):e28403</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22220191</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncogene. 2005 Sep 22;24(42):6367-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16007187</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2015 Aug;21(8):938-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26193342</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2011 Oct 1;17(19):6118-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21705455</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Oncol. 2015 Feb;26(2):259-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25214542</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunother Emphasis Tumor Immunol. 1996 Nov;19(6):387-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9041456</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2012 Mar;142(3):562-571.e2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22115830</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2010 Dec 15;70(24):10060-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21159630</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunity. 2013 Jul 25;39(1):11-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23890060</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2008 Jul 1;68(13):5405-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18593943</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Cancer. 2009 May 15;124(10):2353-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19170204</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Immunol Res. 2013 Aug;1(2):112-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24409449</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Transl Oncol. 2012 Aug;5(4):297-304</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22937182</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nucleic Acids Res. 2009 Jan;37(1):1-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19033363</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Mol Genet. 2015 Jun 1;24(11):3192-205</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25721402</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2010 Mar;138(3):958-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19914252</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Genet. 2006 May;38(5):500-1</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16642009</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncotarget. 2014 Jun 30;5(12):4011-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24994117</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Bioinformatics. 2010 Dec 03;11:590</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21129181</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Genome Biol. 2004;5(10):R80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15461798</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioinformatics. 2004 Feb 12;20(3):307-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14960456</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Opt Lett. 2014 Jun 15;39(12):3523-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24978527</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Genome Biol. 2013 Apr 29;14(4):R34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23618380</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 2010 Jul 1;115(26):5376-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20410506</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Asian Pac J Cancer Prev. 2015;16(9):3635-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25987014</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stat Appl Genet Mol Biol. 2004;3:Article3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16646809</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biostatistics. 2007 Jan;8(1):118-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16632515</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nucleic Acids Res. 2002 Jan 1;30(1):207-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11752295</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2013 Jan 1;19(1):28-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23258741</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Genome Med. 2014 Oct 28;6(10):80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25419236</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Genes Immun. 2005 Jun;6(4):319-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15789058</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Breast Cancer Res. 2009;11(2):R15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19272155</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Surg Res. 2011 May 15;167(2):207-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19896677</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Cutan Med Surg. 1996 Dec;15(4):336-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9069601</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Med Genomics. 2012 Sep 14;5:41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22980038</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23193258</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2014 Jul 15;20(14):3818-29</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24916698</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18490-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19001271</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2001 Jul 1;167(1):98-106</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11418637</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Bioinformatics. 2007 Nov 02;8:427</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17980031</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Protoc. 2009;4(1):44-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19131956</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2014 Sep 20;32(27):2959-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25071121</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Opin Rheumatol. 2013 Mar;25(2):248-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23249830</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2907-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10077610</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2009 Dec 1;69(23):9065-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19920198</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Cancer. 1993 Jun;67(6):1372-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8390286</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Opin Oncol. 2015 Nov;27(6):433-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26418235</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2008 Mar 1;14(5):1413-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18316563</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>